In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Exploring the Full Potential of Risk-Sharing Agreements Between Pharma Companies and Payors

Executive Summary

Health systems, health insurance companies, and other payors around the world are trying to strike the right balance between containing costs and giving patients access to innovative therapies. In doing so, they are putting the traditional pharmaceutical pricing model under intense pressure. Overall health care cost inflation, increasing market-access restrictions, and the growing use of cost-effectiveness assessments make it highly likely that the use of risk-sharing agreements will rise. Pharmaceutical companies that take an integrated approach to risk sharing can design deals that create benefits for themselves and payors.

You may also be interested in...

Reimbursement: The New Biopharma Investment Hurdle

With a growing number of expensive therapeutics entering the market and rising pressures to contain costs, gauging reimbursement is now a crucial element deal makers must evaluate.

QUOTED. 4 March 2021. Meghan Scanlon.

Boston Scientific has agreed to pay $1.07bn to acquire Lumenis’ surgical laser business from Baring Private Equity Asia. See what Meghan Scanlon, president of Boston Scientific’s urology and pelvic health business, said about it here.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts